1946. Efficacy of Approved versus Unapproved Vaccines for SARS-CoV-2 Infection in Randomised Blinded Clinical Trials

BACKGROUND: Five SARS-CoV-2 vaccines are approved in North America and/or Europe: Pfizer/BioNTech, Moderna, Janssen, Oxford-AstraZeneca and Novavax. Other vaccines have been developed, including Sinopharm, SinoVac, QazVac, Covaxin, Soberana, Corbevac, Medicago, Clover and Cansino, but are not approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, Andrea Perez, Pilkington, Victoria, Hill, Andrew, Pepperrell, Toby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752549/
http://dx.doi.org/10.1093/ofid/ofac492.1573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752549/
http://dx.doi.org/10.1093/ofid/ofac492.1573

Ejemplares similares